Question 1

What is BioCryst Pharmaceuticals's deferred tax assets and other non-current assets?

Accepted Answer

BioCryst Pharmaceuticals (BCRX) reported deferred tax assets and other non-current assets of $19.56M in Q2 2026.

Question 2

How has BioCryst Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?

Accepted Answer

BioCryst Pharmaceuticals's deferred tax assets and other non-current assets increased by 444.5% year-over-year, from $3.59M to $19.56M.

Question 3

What is the long-term trend for BioCryst Pharmaceuticals's deferred tax assets and other non-current assets?

Accepted Answer

Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's deferred tax assets and other non-current assets has grown at a 8.3% compound annual growth rate (CAGR), from $3.8M to $5.67M.

Question 4

What does deferred tax assets and other non-current assets mean?

Accepted Answer

Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Line item	June 30, 2026	December 31, 2025
Property and equipment, net	9,058	8,783
Long-term investments	—	61,164
Right of use assets, net	12,608	10,203
Other assets	19,557	5,672
Total assets	$557,851	$514,158
Liabilities and Stockholders’ Deficit
Current liabilities:
Accounts payable	$11,459	$15,826

Deferred Tax Assets and Other Non-Current Assets at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about BioCryst Pharmaceuticals's deferred tax assets and other non-current assets.

BioCryst Pharmaceuticals BCRX Deferred Tax Assets and Other Non-Current Assets